Basilea Pharmaceutica
在场
Basilea Pharmaceutica 是一家在股票代码 BPMUF (CH) 下上市的公司。
高管
查看带有其 16 名主要高管的组织结构图
Basilea Pharmaceutica 搜索最多的简介
- David Veitch, Chief Executive Officer
- Martin Nicklasson, Member of the Board of Directors
- Domenico Scala, Chairman of the Board
创建提醒
跟踪 Basilea Pharmaceutica 的高管变动
药店
Basilea Pharmaceutica 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Basilea Pharmaceutica 的最新新闻稿
- https://www.basilea.com/news/news?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=1518&type=1546938654&cHash=8de255deec1d60e536346929229d46d6
- https://www.basilea.com/news/news?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=1516&type=1546938654&cHash=7af1fce2ad0a11ddb10cb2503b8eb35f
- https://www.basilea.com/news/news?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=1514&type=1546938654&cHash=a4fc203a17cfc676459cbbacfbc060f2
- https://www.basilea.com/news/news/strong-cresembar-isavuconazole-sales-performance-in-europe-triggers-usd-25-million-sales-milestone-payment-to-basilea?type=1546938654
- https://www.basilea.com/news/news/european-commission-decision-to-approve-the-pediatric-use-of-antifungal-cresembar-isavuconazole-and-extension-of-market-exclusivity-triggers-chf-10-million-milestone-payment-to-basilea?type=1546938654
- https://www.basilea.com/news/news/basilea-reports-strong-2024-half-year-results-and-significantly-increases-full-year-revenue-and-profit-guidance?type=1546938654
- https://www.basilea.com/news/news/basilea-partners-oncology-drug-candidate-lisavanbulin-with-glioblastoma-foundation?type=1546938654
- https://www.basilea.com/news/news/basilea-reports-presentation-of-new-data-for-ceftobiprole-zevterar-at-escmid-global-2024?type=1546938654
- https://www.basilea.com/news/news/strong-cresembar-isavuconazole-sales-performance-in-asia-pacific-and-china-triggers-milestone-payment-to-basilea?type=1546938654
- https://www.basilea.com/news/news/basilea-awarded-carb-x-grant-to-develop-recently-acquired-novel-class-of-antibiotics?type=1546938654
- View more press releases Close
通过电子邮件
